HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Fereshteh Haghighi Selected Research

herniarin

4/2014Enhancement of cisplatin cytotoxicity in combination with herniarin in vitro.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Fereshteh Haghighi Research Topics

Disease

3Neoplasms (Cancer)
01/2021 - 01/2014
2Transitional Cell Carcinoma
04/2014 - 03/2014
1Virus Diseases (Viral Diseases)
01/2021
1Atrial Fibrillation
01/2021
1Fragile X Syndrome (Martin Bell Syndrome)
01/2021
1Liver Diseases (Liver Disease)
01/2021
1Intellectual Disability (Idiocy)
01/2021
1Carcinoma (Carcinomatosis)
03/2014
1Urinary Bladder Neoplasms (Bladder Cancer)
01/2014

Drug/Important Bio-Agent (IBA)

23- (4,5- dimethyl- 2- thiazolyl)- 2,5- diphenyl- 2H- tetrazolium bromideIBA
04/2014 - 03/2014
2CoumarinsIBA
04/2014 - 01/2014
2coumarinIBA
03/2014 - 01/2014
1CalciumIBA
01/2021
1Proteins (Proteins, Gene)FDA Link
01/2021
17-hydroxycoumarin (umbelliferone)IBA
04/2014
1herniarinIBA
04/2014
1diversinIBA
03/2014
17-isopentenyloxycoumarinIBA
01/2014
15- hydroxy- 6- methoxy- 7- (3- methyl- but- 2- enyloxy)- 2H- 1- benzopyran- 2- oneIBA
01/2014

Therapy/Procedure

1Therapeutics
03/2014
1Drug Therapy (Chemotherapy)
03/2014